We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEATW icon
176
Heartbeam Inc Warrant
BEATW
$200K ﹤0.01%
500,000
-1
-0% –
AREB
177
DELISTED
American Rebel
AREB
– –
0
– –
VTAK icon
178
Catheter Precision
VTAK
$952K
$192K ﹤0.01%
1,100
-1,521
-58% -$351K
FGIWW
179
FGI Industries Warrant
FGIWW
$180K
$187K ﹤0.01%
933,333
-1
-0% –
MOTS
180
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$183K ﹤0.01%
+18,199
New +$210K
GROMW
181
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$178K ﹤0.01%
24,100
-1
-0% -$3
SKYAW
182
SkyAI Inc
SKYAW
$263K
$166K ﹤0.01%
1,176,000
-1
-0% –
DCOY
183
Decoy Therapeutics
DCOY
$2.31M
$163K ﹤0.01%
+76
New +$174K
TNONW icon
184
Tenon Medical Inc Warrant
TNONW
$142K ﹤0.01%
+1,780,000
New +$186K
ADXN
185
Addex Therapeutics
ADXN
$138K ﹤0.01%
+13,200
New +$191K
CISS
186
C3is
CISS
$166K
– –
0
– –
SBEV.WS
187
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$108K ﹤0.01%
904,000
-1
-0% –
BIAFW icon
188
bioAffinity Technologies
BIAFW
$150K
$105K ﹤0.01%
204,082
-1
-0% –
MTEKW icon
189
Maris-Tech Ltd Warrants
MTEKW
$959K
$88.3K ﹤0.01%
1,261,058
-1
-0% –
GMVDW
190
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$87.7K ﹤0.01%
28,571
-1
-0% -$2
CINGW icon
191
Cingulate Inc Warrants
CINGW
$39.6K
$86.1K ﹤0.01%
410,000
-1
-0% –
CFRX
192
DELISTED
ContraFect Corporation
CFRX
$83.6K ﹤0.01%
55,742
-30,258
-35% -$47.8K
GROY.WS
193
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$80.6K ﹤0.01%
448,000
-1
-0% –
ONFOW icon
194
Onfolio Holdings Warrant
ONFOW
$73.9K
$80K ﹤0.01%
400,000
-1
-0% –
LCFYW icon
195
Locafy Ltd Warrant
LCFYW
$363K
$62.4K ﹤0.01%
12,121
-1
-0% -$4
NEXRW
196
Nexera Technologies Ltd Warrant
NEXRW
$94.1K
$55.7K ﹤0.01%
480,769
-1
-0% –
HSCSW icon
197
HeartSciences Inc Warrant
HSCSW
$55.4K ﹤0.01%
352,941
-1
-0% –
RVSNW icon
198
Rail Vision Ltd Warrant
RVSNW
$649K
$54.5K ﹤0.01%
1,089,500
-1
-0% –
PETVW
199
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$54.2K ﹤0.01%
200,000
-1
-0% –
DFSCW
200
DEFSEC Technologies Warrant
DFSCW
$54K ﹤0.01%
120,000
-1
-0% –
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.